Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0126 USD | -1.25% | +26.00% | -42.73% |
02-22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-42.73% | 669K | |
+32.80% | 50.85B | |
+0.04% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.59% | 26.11B | |
-22.23% | 19.13B | |
+8.36% | 13.05B | |
+27.13% | 12.16B | |
+24.68% | 12.08B |
- Stock Market
- Equities
- BXRXQ Stock
- News Baudax Bio, Inc.
- Baudax Bio : Oppenheimer Adjusts Baudax Bio PT to $3 From $7, Maintains Outperform Rating